Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of PKD1 Hypomorphic Alleles

Author:

Ambrosini Enrico1ORCID,Montanari Francesca2,Cristalli Carlotta Pia2,Capelli Irene3,La Scola Claudio4ORCID,Pasini Andrea4,Graziano Claudio5ORCID

Affiliation:

1. Medical Genetics Unit, University of Parma, 43126 Parma, Italy

2. Medical Genetics Unit, IRCCS Sant’Orsola University Hospital of Bologna, 40138 Bologna, Italy

3. Nephrology Unit, IRCCS Sant’Orsola University Hospital of Bologna, 40138 Bologna, Italy

4. Paediatric Nephrology Program, Paediatrics Unit, IRCCS Sant’Orsola University Hospital of Bologna, 40138 Bologna, Italy

5. Medical Genetics Unit, AUSL Romagna, 47522 Cesena, Italy

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of kidney failure in adult life. Rarely, ADPKD can be diagnosed in utero or in infancy, and the genetic mechanism underlying such severe presentation has been shown to be related to reduced gene dosage. Biallelic PKD1 variants are often identified in early onset ADPKD, with one main pathogenic variant and a modifier hypomorphic variant showing an in trans configuration. We describe two unrelated individuals with early onset cystic kidney disease and unaffected parents, where a combination of next-generation sequencing of cystic genes including PKHD1, HNF1B and PKD1 allowed the identification of biallelic PKD1 variants. Furthermore, we review the medical literature in order to report likely PKD1 hypomorphic variants reported to date and estimate a minimal allele frequency of 1/130 for this category of variants taken as a group. This figure could help to orient genetic counseling, although the interpretation and the real clinical impact of rare PKD1 missense variants, especially if previously unreported, remain challenging.

Publisher

MDPI AG

Subject

Genetics (clinical),Genetics

Reference37 articles.

1. Adam, M.P., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (1993–2023). Polycystic Kidney Disease, Autosomal Dominant, University of Washington. Available online: https://www.ncbi.nlm.nih.gov/books/NBK1246/.

2. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial;Blais;Nephrol. Dial. Transpl.,2018

3. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease;Rossetti;J. Am. Soc. Nephrol.,2007

4. Autosomal dominant polycystic kidney disease;Torres;Lancet,2007

5. Type of PKD1 mutation influences renal outcome in ADPKD;Chen;J. Am. Soc. Nephrol.,2013

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3